The economic argument for hepatitis B treatment simplification and expansion.

Autor: Razavi-Shearer D; Center for Disease Analysis Foundation, Lafayette, Colorado, USA.
Jazyk: angličtina
Zdroj: Journal of viral hepatitis [J Viral Hepat] 2024 Dec; Vol. 31 Suppl 2, pp. 23-26. Date of Electronic Publication: 2024 May 08.
DOI: 10.1111/jvh.13920
Abstrakt: One component of decisions regarding hepatitis B virus (HBV) treatment simplification and expansion is the economic perspective. Literature was reviewed for studies which provide estimates for the economic impact of simplifying and expanding treatment eligibility. Eight published studies and four unpublished studies were included and all but one subset of one study found that expanding treatment criteria would result in programs that would be at minimum cost-effective and most often highly cost-effective.
(© 2024 The Authors. Journal of Viral Hepatitis published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz: